Effect of Ceftazidime-Avibactam on Carbapenemase-Producing Klebsiella Pneumoniae
NCT07369518 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-01-27
Summary
Specimen Collection : Clinical specimens included blood, urine, bronchoalveolar lavage fluid, wound, peritoneal fluid, and tracheal aspirate obtained from patients with suspected bacterial infections collected in dry sterile well-closed plastic cups.
Bacterial identification by Gram stain, culture and biochemical rections
* analysisThe resistance pattern of the isolates will be detected by disc diffusion method.
* phenotypic detection of carbapenemases. • Detection of carbapenem resistance genes (KPC, VIM, IMP, OXA-48, NDM) by conventional PCR.
Conditions
- ISOLATION OF KLEB. by Culture on macConkey Agar
- Antibiotic Sensitivity Testing of Different Antibiotics According to Clsi 25
- Effect of Ceftazidime-Avibactam on Carbapenemase-Producing Klebsiella Pneumoniae
- Detection of Resistance Gene in Isolates Using Conventional Pcr
- Detection of Some Virulence Genes Using Conventional Pcr
Interventions
- GENETIC
-
. - Genotypic detection of carbapenemase genes by conventional PCR.
Specimen Collection : Clinical specimens included blood, urine, bronchoalveolar lavage fluid, wound, peritoneal fluid, and tracheal aspirate obtained from patients with suspected bacterial infections collected in dry sterile well-closed plastic cups. Bacterial identification by Gram stain, culture and biochemical rections - analysisThe resistance pattern of the isolates will be detected by disc diffusion method. - phenotypic detection of carbapenemases. • Detection of carbapenem resistance genes (KPC, VIM, IMP, OXA-48, NDM) by conventional PCR.
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-01-31
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- Egypt
Study Locations
More Related Trials
-
Evaluation of the Role of Acetyl Cysteine in Ventilator Associated Pneumonia by Carbapenem Resistance Klebsiella
NCT07097727 ·Status: COMPLETED ·Phase: PHASE1
-
Duration of Antibiotics for the Treatment of Gram-negative Bacilli Bacteremia
NCT01737320 ·Status: COMPLETED ·Phase: NA
-
Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection
NCT02482961 ·Status: COMPLETED
-
A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection
NCT06966284 ·Status: RECRUITING
-
Comparison of the Clinical Efficacy of Ampicillin/Sulbactam and Cefoperazone/Sulbactam Against Multidrug Resistant Acinetobacter Baumannii Infections in Critically Ill Patients
NCT07118384 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Colistin Based Antibiotic Therapy
NCT04764058 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Comparison of Bloodstream Infections With Carbapenem Hetero-resistant vs Carbapenem Resistant Klebsiella Pneumoniae
NCT04229498 ·Status: UNKNOWN
-
Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections
NCT05210387 ·Status: TERMINATED ·Phase: NA
-
Comparative Study of Clinical Outcomes and Safety Between Colistin and Tigecycline
NCT06893835 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Different Dosing Strategies of Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections
NCT06843668 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Cefazolin Versus Antistaphylococcal Penicillins for Methicillin Susceptible Staphylococcus Aureus Bacteremia
NCT07186894 ·Status: ACTIVE_NOT_RECRUITING
-
CONTinuous Infusion Versus Intermittent Dosing of ceftaZidime/AVIbactam in Critically Ill Patients
NCT06811727 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Safety and Efficacy Study of High Dose Colistin
NCT02162966 ·Status: UNKNOWN ·Phase: PHASE4
-
PK and Safety Evaluation of Daptomycin in Children Ages 2-6 With Proven or Suspected Gram-positive Infections
NCT00679835 ·Status: COMPLETED ·Phase: PHASE1
-
Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China
NCT03245632 ·Status: UNKNOWN
-
Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infection
NCT06051513 ·Status: RECRUITING ·Phase: NA
-
Dose Optimization by Pharmacokinetic/Pharmacodynamic of Antibiotics to Improve Clinical Outcome of Carbapenem Resistant Klebsiella Pneumoniae Bloodstream Infections in Critically Ill Patients at Phramongkutklao Hospital
NCT05862402 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of Vancomycin Treatment of Infections Due to Staphylococcus Aureus
NCT00862862 ·Status: TERMINATED
-
Clinical Efficacy of Combination Therapy Based on High-dose Biapenem in CRKP Infections
NCT04552444 ·Status: UNKNOWN
-
Impact of New CLSI Guidelines on Antibiotic Susceptability Pattern
NCT01352377 ·Status: UNKNOWN
-
Pharmacokinetics of Ceftazidime-avibactam Among Critically-ill Patients Receiving CVVHDF
NCT04358991 ·Status: COMPLETED
-
Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia
NCT00505258 ·Status: WITHDRAWN ·Phase: PHASE2
-
Turkish Prospective Cohort Study on Carbapenem Resistant Klebsiella Pneumonia Bacteremia
NCT03597841 ·Status: COMPLETED
-
Healthcare-Associated Infections in Ukraine and the Activity of 4-Thiazolidinone Derivatives Against Related Pathogens
NCT06508398 ·Status: COMPLETED
-
Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)
NCT01597973 ·Status: COMPLETED ·Phase: PHASE3